Beta

Spending
Congress
Stocks
Lobbying

Spending
Congress
Stocks
Lobbying

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Congress
Stocks
Lobbying

PHARMACEUTICAL RESEARCH AND MANUFACTURERS… — Receipts Report

LD-2 disclosure · 2nd Quarter - Report

PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA

via THORN RUN PARTNERS

2nd Quarter (Apr 1 - June 30) · 2026Posted Jul 20, 2026Filing document ↗LDA record ↗

Income$40Kfee reported

Client

Name: PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA
Description: Pharmaceutical Industry Association
Location: District of Columbia · United States of America

Registrant

Firm: THORN RUN PARTNERS
Description: Government Affairs Firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Health Issues
Promoting pharmaceutical research and development and ensuring access to medicines.
LobbyistsBEAU SCHUYLER · YUL EDWARDS
Covered position (BEAU SCHUYLER): Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre
Covered position (YUL EDWARDS): Legislative Assistant/Chief of Staff, Rep. Danny K. Davis; Legislative Director, Rep. Frank Ballance, Jr.
TargetedSENATE · HOUSE OF REPRESENTATIVES · Health & Human Services, Dept of (HHS)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.